Hints and tips:
...and Serbia 200th day of the Hamas-Israel conflict after Hamas launched an attack on Israel on October 7 last year UK: 100th anniversary of both the first radio broadcast by a British monarch, George V...
...Arrival is merging with Kensington Capital Acquisition Corp V, paying a huge premium in order to add $300mn to its balance sheet. It is a desperate move that is unlikely to trigger a Spac revival....
...“Anvisa’s delays in approving Sputnik V are, unfortunately, of a political nature,” the Russian Direct Investment Fund wrote on Twitter....
...said there were “fine people” among the white supremacists at a deadly protest in Charlottesville in 2017 was also slower than campaigners hoped, he noted, but once Ken Frazier of pharmaceutical group Merck...
...change Siemens initiated sweeping change following the slush fund scandal, which was most clearly visible in the appointment of Gerhard Cromme, from ThyssenKrupp, as chairman, and Peter Löscher, from Merck...
...Evercore v Lazard: the boutique turf war Boutique investment bank results are streaming in, and with two of the biggest advisory shops posting their annual figures, we thought it might be a good time to...
...In the UK, the Sackler name appears on an array of cultural landmarks, including a gallery at the Serpentine, a courtyard at the V&A, an education centre at the Dulwich Picture Gallery, an escalator at Tate...
...Andrew Jack is the FT’s head of aggregation and editor of FirstFT Photographs: V.A....
...Top shareholdings: Resolute Forest Products; Dex Media; Cooper Tire & Rubber Company; IBM; Merck & Co; New York Times. Portfolio Value: $2.5bn....
...“However, unlike some, we don’t feel that equities need a V-shaped profile to make further gains....
...But Merck’s superior gross margins and the strength of its near-term drug pipeline won this round....
...Wyeth, Merck and other drugmakers face thousands of such suits potentially worth billions of dollars. The issue in the case is whether state law claims are pre-empted under federal law....
...Bad news for leading drug makers Merck and Schering-Plough undercut positive sentiment Monday....
...Manufacturer victories would be good news for an industry smarting from the Vioxx withdrawal, which cost Merck more than $6bn in legal and settlement costs....
...His rival, G.V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition